Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy

Investigative Ophthalmology and Visual Science

Volumn 43, Issue 4, 2002, Pages 1104-1108

  Gerl, Verena B ^a   Bohl, Jürgen ^a   Pitz, Susanne ^a   Stoffelns, Bernhard ^a   Pfeiffer, Norbert ^a   Bhakdi, Sucharit ^a  

^a Department of Ophthalmology ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3D; COMPLEMENT MEMBRANE ATTACK COMPLEX; VITRONECTIN;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; CHOROID CAPILLARY LAYER; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT DEPOSITION; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUSEN; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; STAINING; UVEA MELANOMA; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CAPILLARIES; COMPLEMENT ACTIVATION; COMPLEMENT C3D; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT PATHWAY, ALTERNATIVE; DIABETIC RETINOPATHY; HUMANS; IMMUNOENZYME TECHNIQUES; MELANOMA; MIDDLE AGED; RETINAL VESSELS; UVEAL NEOPLASMS; VITRONECTIN;

EID: 0036210286     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. The Diabetic Control and Complications Trial Research Groups: The effect of intensive treatment of diabetes on the development and progression of long-term complications in the insulin-dependent diabetes mellitus
2. Treatment of diabetic retinopathy
3. The Wisconsin Epidemiologic study of diabetic retinopathy: A review
4. The pathophysiology of diabetic complications: How much does the glucose hypothesis explain?
5. Diabetic choroidopathy: Light and electron microscopic observations of seven cases
6. Changes in diabetic choroidal vasculature: Scanning electron microscopy findings
7. Diabetic choroidal and iris vasculature: Scanning electron microscopy findings
8. High resolution histologic analysis of the human choroidal vasculature
9. Choriocapillaris degeneration and related pathologic changes in human diabetic eyes
10. Complement and atherogenesis: Binding of CRP to degraded, nonoxidized LDL enhances complement activation
11. Functions and relevance of the terminal complement sequence
12. Molecular organization and function of the complement system
13. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease
14. Location, substructure and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration
15. Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque
16. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium
17. Detection of activated complement complex C5b-9 and complement receptor C5a in skin biopsies of patients with systemic sclerosis (scleroderma)
18. Deposition of membrane attack complex in cutaneous lesions of lupus erythematosus
19. Complement in acute and chronic arthritides: Assessment of C3c, C9, and protein (CD59) in synovial membrane
20. Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease
21. SP-40,40 is a constituent of Alzheimer's amyloid
22. Complement and the direct mediation of immune glomerular injury: A new perspective
23. Renal C3 synthesis in idiopathic membranous nephropathy: Correlation to urinary C5b-9 excretion
24. Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephritic syndrome
25. Local activation of the complement system in endoneurial microvessels of diabetic neuropathy
26. Role of vitronectin and its receptors in haemostasis and vascular remodeling
27. Fibronectin, laminin, vitronectin and their receptors at newly formed capillaries in proliferative diabetic retinopathy
28. Integrin chatter and vascular function in diabetic retinopathy
29. Vitronectin gene expression in the adult retina
30. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins